Skip to content Skip to footer

Infection Prevention Guidelines Reevaluated: CDC Calls for Revision Amidst Controversy

On January 23, 2023, the Centers for Disease Control and Prevention (CDC) indicated their intention to revise the 2023 proposals concerning the spread of dangerous pathogens within healthcare facilities. In doing so, they have requested the Healthcare Infection Control Practices Advisory Committee (HICPAC) reassess its existing recommendations, expressing concerns about potential hazards and underscoring the urgent need for alterations. These adjustments necessitated, primarily revolve around transmission categories, previously divided into touch and air and the nuanced dynamics between large versus small droplet transmission.

The CDC is now favoring a broader, more fluid interpretation of particle size transmission. Controversies have arisen due to these guideline suggestions, notably within publications such as ‘Infection Control Today’, voicing major reservations about the potential harm. The CDC echoes these concerns, highlighting the requirement for comprehensive scrutiny of the revised draft. In July 2023, a commentary suggested HICPAC implement recommendations by incorporating experts from various fields, including aerosol scientists, industrial hygienists, and respiratory protection specialists.

Seeing merit in this approach, CDC has indicated its intentions of progressively incorporating a more diverse pool of experts into the decision-making process and HICPAC perspectives. Of significant concern are the proposed allowances for the use of surgical masks over N95 respirators in treating patients with airborne infections, and an absence of provisions for air quality standards. The CDC queried if surgical masks could serve as an alternative to N95 respirators in cases of airborne pathogen transmission while stressing the need to avoid misconceptions about the equal effectiveness of face masks and NIOSH approved respirators, tripping journalistic alarm bells.

The absence of guidelines pertaining to source control further intensifies concerns, with the CDC placing emphasis on the necessity to extensively implement source control in healthcare facilities, given its critical role in curbing respiratory pathogen spread. These considerations particularly impact immunocompromised individuals who often frequent healthcare facilities and experience fears regarding their safety. CDC’s announcement regarding the acknowledgment of the importance of ventilation controls and its decision to address this issue separately could signify a shift towards improved pre-emptive protection measures against new and emerging pathogens in light of COVID-19 related learnings. A proactive, rather than reactive, approach is encouraged, emphasizing the importance of early implementation of precautions.

The CDC warns that interventions focusing solely on preventing severe disease may overlook significant disabling sequelae. Disturbingly, as related events unfold, deficiencies in our preparedness for future pandemics are becoming apparent. This lack of preparedness, combined with discouragement against the use of N95 masks and inadequate ventilation requirements in the 2023 proposals, threatens to weaken our line of defence against future large-scale health crises. This further highlights the importance of effective source controls – including N95 masks and negative pressure rooms – despite perceived burdens. With emerging threats like the cell-cultured mutated SARS-CoV-2 related virus demonstrating a 100% fatality rate in specific rodent species, the urgency to prepare adequately for future pandemics is clear.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]